Revolutionizing Drug Efficacy with COBALAMINUSION™ Technology
In the world of pharmaceuticals, the quest for enhancing drug efficacy and bioavailability is relentless. This pursuit has led to a groundbreaking innovation: COBALAMINUSION™ Technology. At the heart of this technology lies Vitamin B12, a crucial element in drug metabolism. Recent studies highlight that a deficiency in Vitamin B12 can significantly reduce the absorption and metabolism of drugs, whether administered orally or via injections. COBALAMINUSION™ Tech, since its inception in 2012, has been at the forefront of addressing this challenge.
The Vitamin B12 Connection
Research published by Caldwell J, Gardner I, Swales N. in Toxicol Pathol (1995) and Martinez MN, Amidon GL. in J Clin Pharmacol (2002) sheds light on how B12 deficiency leads to diminished drug metabolism, by as much as 50%. Vitamin B12 plays a pivotal role in hematopoiesis, neuro-cognitive functions, and genetic integrity, impacting the binding effect of hormones and drugs.
The Breakthrough of COBALAMINUSION™
COBALAMINUSION™ Technology is based on the hypothesis that infusing Vitamin B12 molecules into drugs could enhance their effectiveness. The results have been nothing short of phenomenal. This method has shown to improve drug absorption and metabolism by 200%, a significant leap in pharmaceutical technology.
Patents and Innovations
Till date, COBALAMINUSION™ Tech has filed 18 patents in drug bioavailability and delivery enhancement technology. This pioneering approach has been aiding pharmaceutical companies globally in creating more efficient medicines and enhancing drug delivery mechanisms.
Research and Clinical Trials
A randomized clinical trial is set to compare biomarker responses after supplementation with oral and intramuscular vitamin B12. This trial aims to understand the clinical and functional signs of sub-clinical vitamin B12 deficiency and its impact on medication efficacy. Electronic compliance monitoring will be utilized to mitigate noncompliance, a common issue in oral treatments.
COBALAMINUSION™ and 3rd Degree Products
In the realm of Performance Enhancing Drugs (PEDs) and anabolic hormones, COBALAMINUSION™ has found a significant application. 3rd Degree products are the only PEDs and anabolic hormones currently utilizing this advanced technology, Means with the same API and Same Dosage you will get Twice the better results. 3rd Degree Pharma and Cobalaminusion Tech are setting a new benchmark in the Endocrinology medicine industry.
COBALAMINUSION™ Technology is not just a scientific advancement; it's a beacon of hope for enhancing drug efficacy and improving public health. By harnessing the power of Vitamin B12, this technology opens new avenues in the pharmaceutical landscape, making medications more effective and patient outcomes more promising. Stay tuned for more updates on this revolutionary technology as it reshapes the future of medication and treatment.